Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY Screening Procedures

2025 HCPCS code M1029

Performance measure exclusion modifier - primary headache; imaging of the head (CT or MRI) obtained.

2025 HCPCS code M1059

This HCPCS code is used to report patients receiving palliative care or hospice services during a performance period for quality measurement purposes; it is not for reimbursement.

2025 HCPCS code M1040

This HCPCS code reports a diagnosis of lumbar idiopathic or congenital scoliosis; it's for quality measurement, not reimbursement.

2025 HCPCS code M1011

This HCPCS code reports the discontinuation of treatment and discharge of a patient (14 years or older) with lower leg, foot, or ankle impairments; used for quality measurement reporting, not reimbursement.

2025 HCPCS code M1007

This HCPCS code reports assessment and classification of disease activity in ≥50% of outpatient encounters for rheumatoid arthritis (RA) patients aged 18+ within a 12-month period.It's for quality measurement, not reimbursement.

2025 HCPCS code M1054

This HCPCS code reports patient urgent care visits during a performance period for quality measure reporting; it's not for reimbursement.

2025 HCPCS code M1070

Reports that a patient aged 65+ with a fall history wasn't screened for fall risk, and no reason was given.

2025 HCPCS code M1046

Documents functional status measurement 9-15 months post-op, with Oxford Knee Score (OKS) < 37 or Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR.) < 71.

2025 HCPCS code M1051

Сообщите этот код, если у пациента был рак, острый перелом или инфекция поясничного отдела позвоночника, нервно-мышечный, идиопатический или врожденный поясничный сколиоз.

2025 HCPCS code M1018

This code is for patients 35+ years old with active cancer diagnosis/history (excluding basal/squamous cell skin carcinoma), heavy smokers, or those undergoing lung cancer screening and excluded from CT imaging study tracking.

2025 HCPCS code M1010

Reports discontinuation of hip impairment treatment for patients ≥14 years, resulting in discharge.

2025 HCPCS code M1027

Performance Measure Reporting Modifier for Head CT/MRI for Primary Headache Evaluation.

2025 HCPCS code M1020

This code is used to report when adolescent patients do not achieve remission from depression or dysthymia within 12 months (± 60 days) of diagnosis, as measured by specific assessments.

2025 HCPCS code M1056

This HCPCS Level II code (M1056) is used for quality measurement reporting to document patients prescribed anticoagulants despite contraindications (e.g., bleeding history, drug interactions).

2025 HCPCS code M1052

Indicates leg pain was not measured using a visual analog scale or numeric pain scale at approximately one year post-surgery.

2025 HCPCS code M1013

Reports discontinuation of treatment for shoulder impairment in patients ≥14 years, with discharge documented; used for quality measurement, not reimbursement.

2025 HCPCS code M1008

This HCPCS code reports that for patients aged 18+ with rheumatoid arthritis (RA), disease activity assessment was done in less than 50% of outpatient encounters over 12 months.It's for quality measurement, not reimbursement.

2025 HCPCS code M1069

This HCPCS code reports that a patient aged 65+ with a fall history had a fall risk assessment within 12 months.It's for quality reporting, not reimbursement.

2025 HCPCS code M1041

Reports patient care for fracture, infection, or cancer related to the lumbar spine or idiopathic, neuromuscular, or congenital scoliosis.

2025 HCPCS code M1069

يشير رمز HCPCS هذا إلى أن مريضًا يبلغ من العمر 65 عامًا أو أكثر ولديه تاريخ سقوط قد خضع لتقييم مخاطر السقوط في غضون 12 شهرًا. هذا للإبلاغ عن الجودة وليس السداد.

2025 HCPCS code M1069

이 HCPCS 코드는 낙상 병력이 있는 65세 이상의 환자가 12개월 이내에 낙상 위험 평가를 받았음을 보고합니다. 이는 환급이 아니라 품질 보고를 위한 것입니다.

2025 HCPCS code M1069

Iniulat ng HCPCS code na ito na ang isang pasyente na may edad na 65+ na may kasaysayan ng pagbagsak ay may pagtatasa sa panganib sa pagbagsak sa loob ng 12 buwan. Ito ay para sa pag-uulat ng kalidad, hindi pagbabayad.

2025 HCPCS code M1060

Este código HCPCS informa sobre las muertes de los pacientes antes de que finalice un período de desempeño para medir la calidad, no para reembolsar.

2025 HCPCS code M1060

Mã HCPCS này báo cáo trường hợp tử vong của bệnh nhân trước khi kết thúc giai đoạn hiệu suất để đo lường chất lượng, không phải hoàn trả.

2025 HCPCS code M1060

该HCPCS守则在绩效期结束之前报告患者死亡情况，以进行质量评估，而不是报销。

2025 HCPCS code M1060

يُبلغ رمز HCPCS هذا عن وفيات المرضى قبل نهاية فترة الأداء لقياس الجودة وليس السداد.

2025 HCPCS code M1060

이 HCPCS 코드는 환급이 아닌 품질 측정을 위해 성과 기간이 끝나기 전에 환자 사망을 보고합니다.

2025 HCPCS code M1060

Iniulat ng HCPCS code na ito ang pagkamatay ng pasyente bago matapos ang panahon ng pagganap para sa pagsukat ng kalidad, hindi pagbabayad.

2025 HCPCS code M1060

Ce code HCPCS signale les décès de patients avant la fin d'une période de performance à des fins de mesure de la qualité, et non de remboursement.

2025 HCPCS code M1051

환자가 암, 급성 골절 또는 요추나 신경근, 특발성 또는 선천성 요추 척추측만증과 관련된 감염을 앓고 있는 경우 이 코드를 보고하십시오.

2025 HCPCS code M1049

Tình trạng chức năng không được đo bằng Chỉ số Khuyết tật <a href="../medical-coding/reference/ODI" target="_blank" title="Medical Code ODI 2025">Oswestry (ODI</a>) sau ba tháng (sáu đến 20 tuần) sau phẫu thuật.

2025 HCPCS code M1049

لم يتم قياس الحالة الوظيفية باستخدام مؤشر Oswestry للإعاقة (<a href="../medical-coding/reference/ODI" target="_blank" title="Medical Code ODI 2025">ODI</a>) بعد ثلاثة أشهر (من ستة إلى 20 أسبوعًا) بعد الجراحة.

2025 HCPCS code M1049

L'état fonctionnel n'a pas été mesuré à l'aide de l'indice de handicap d'Oswestry (<a href="../medical-coding/reference/ODI" target="_blank" title="Medical Code ODI 2025">ODI</a>) trois mois (six à 20 semaines) après la chirurgie.

2025 HCPCS code M1056

Этот код HCPCS уровня <a href="../medical-coding/reference/II" target="_blank" title="Medical Code II 2025">II</a> (<a href="../medical-coding/reference/M1056" target="_blank" title="Medical Code M1056 2025">M1056</a>) используется для отчетов об измерениях качества для документирования пациентов, которым назначают антикоагулянты, несмотря на противопоказания (например, анамнез кровотечения, лекарственное взаимодействие).

2025 HCPCS code M1056

Este código HCPCS de nivel <a href="../medical-coding/reference/II" target="_blank" title="Medical Code II 2025">II</a> (<a href="../medical-coding/reference/M1056" target="_blank" title="Medical Code M1056 2025">M1056</a>) se utiliza para informar sobre las mediciones de calidad a fin de documentar a los pacientes a los que se les recetaron anticoagulantes a pesar de las contraindicaciones (por ejemplo, antecedentes de hemorragias, interacciones farmacológicas).

2025 HCPCS code M1056

이 HCPCS 레벨 <a href="../medical-coding/reference/II" target="_blank" title="Medical Code II 2025">II</a> 코드 (<a href="../medical-coding/reference/M1056" target="_blank" title="Medical Code M1056 2025">M1056</a>) 는 금기 사항 (예: 출혈 이력, 약물 상호 작용) 에도 불구하고 항응고제를 처방받은 환자를 문서화하기 위한 품질 측정 보고에 사용됩니다.

2025 HCPCS code M1055

有报告称，患有冠状动脉或其他血管疾病的患者接受了阿司匹林或其他抗血小板药物。

2025 HCPCS code M1055

Informes de que un paciente con enfermedad arterial coronaria u otra enfermedad vascular recibió aspirina u otro medicamento antiplaquetario.

2025 HCPCS code M1055

Signale qu'un patient atteint d'une maladie coronarienne ou d'une autre maladie vasculaire a reçu de l'aspirine ou un autre médicament antiplaquettaire.

2025 HCPCS code M1056

Mã HCPCS Cấp <a href="../medical-coding/reference/II" target="_blank" title="Medical Code II 2025">II</a> này (<a href="../medical-coding/reference/M1056" target="_blank" title="Medical Code M1056 2025">M1056</a>) được sử dụng để báo cáo đo lường chất lượng để ghi lại bệnh nhân được kê đơn thuốc chống đông máu mặc dù có chống chỉ định (ví dụ: tiền sử chảy máu, tương tác thuốc).

2025 HCPCS code M1056

Ce code HCPCS de niveau <a href="../medical-coding/reference/II" target="_blank" title="Medical Code II 2025">II</a> (<a href="../medical-coding/reference/M1056" target="_blank" title="Medical Code M1056 2025">M1056</a>) est utilisé pour les rapports de mesure de la qualité afin de documenter les patients auxquels on a prescrit des anticoagulants malgré les contre-indications (par exemple, antécédents de saignement, interactions médicamenteuses).

2025 HCPCS code M1049

Ang katayuan ng pag-andar ay hindi sinusukat gamit ang Oswestry Disability Index (<a href="../medical-coding/reference/ODI" target="_blank" title="Medical Code ODI 2025">ODI</a>) sa tatlong buwan (anim hanggang 20 linggo) pagkatapos ng operasyon.

2025 HCPCS code M1055

Báo cáo rằng một bệnh nhân bị động mạch vành hoặc bệnh mạch máu khác đã nhận được aspirin hoặc một loại thuốc chống tiểu cầu khác.

2025 HCPCS code M1055

تشير التقارير إلى أن مريضًا مصابًا بالشريان التاجي أو أمراض الأوعية الدموية الأخرى قد تلقى الأسبرين أو أي دواء آخر مضاد للصفيحات.

2025 HCPCS code M1055

Berichten zufolge erhielt ein Patient mit einer Koronararterie oder einer anderen vaskulären Erkrankung Aspirin oder ein anderes Thrombozytenaggregationshemmer.

2025 HCPCS code M1055

관상동맥이나 다른 혈관 질환을 앓고 있는 환자가 아스피린이나 다른 항혈소판제를 투여받았다는 보고가 있습니다.

2025 HCPCS code M1055

Сообщает о том, что пациент с ишемической артерией или другим сосудистым заболеванием получал аспирин или другой антиагрегантный препарат.

2025 HCPCS code M1056

يُستخدم رمز HCPCS من المستوى <a href="../medical-coding/reference/II" target="_blank" title="Medical Code II 2025">الثاني</a> (<a href="../medical-coding/reference/M1056" target="_blank" title="Medical Code M1056 2025">M1056</a>) لتقارير قياس الجودة لتوثيق مضادات التخثر التي يصفها المرضى على الرغم من موانع الاستعمال (مثل تاريخ النزيف والتفاعلات الدوائية).

2025 HCPCS code M1056

Dieser <a href="../medical-coding/reference/II" target="_blank" title="Medical Code II 2025">HCPCS-Level-II-Code</a> (<a href="../medical-coding/reference/M1056" target="_blank" title="Medical Code M1056 2025">M1056</a>) wird für die Berichterstattung über Qualitätsmessungen verwendet, um zu dokumentieren, dass Patienten trotz Kontraindikationen (z. B. Blutungsgeschichte, Arzneimittelwechselwirkungen) Antikoagulanzien verschrieben wurden.

2025 HCPCS code M1056

这份 HCPCS <a href="../medical-coding/reference/II" target="_blank" title="Medical Code II 2025">二</a>级代码 (<a href="../medical-coding/reference/M1056" target="_blank" title="Medical Code M1056 2025">M1056</a>) 用于质量测量报告，以记录患者尽管有禁忌症（例如出血史、药物相互作用）仍处方抗凝剂。